Cancer vaccine from NK | IDRA Message Board Posts

Idera Pharmaceuticals, Inc

  IDRA website

IDRA   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1603 of 1620  at  1/31/2020 6:26:59 PM  by


 In response to msg 1602 by  cert77
view thread

Re: Cancer vaccine from NK

 First look at the CEO's reputation. Next remember these are mostly phase 1-2 findings. We know how ORR/CR numbers change as you go up in phase. Do you have any qualms about a company touting 56% complete response rate across a number of tumor types. Let's look at the numbers closer. For instance when you break down where the CR's come from they mostly occurred in bladder cancer which already has a 75-95% survival rate at 5 years. The data here is impressive, I agree for this a relatively easy to treat cancer. In terms of indolent Non Hodgkins lymphoma, first it is a blood borne tumor and NOT a solid tumor. It is a slow growing cancer that often isn't even treated at the onset. The 5 year survival depending on the severity and type is in the 55-95% range.
So if you look at the pooled data they tout (56%), the bulk of the CR's are in bladder cancer with 43/55 or 78% CR rate. That leaves 26/106 CR rate of 24% for the other tumors they treated. If you throw out the blood cancer NHL, then you are left with 16/85 or 19% CR for the solid tumors. Actually impressive for some of these difficult to treat cancers but a little PR manipulation to headline a 56% CR don't you think. Agree the market liked it but it was mostly in response to a CR in ONE pancreatic patient. The overall CR for pancreatic was 1/9 or 11%, a known very cold hard to treat tumor. We shall see if these early "encouraging" results hold up.

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 4     Views: 86
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 All rights reserved. User Agreement
Financial Market Data provided by